Cigna Corporation Stock News

We pick high-growth dividend stocks that have rapidly grown their dividends in the recent past rather than offering a high current yield. We use our proprietary models to rate quantitatively and quali

In the latest trading session, Cigna (CI) closed at $294.45, marking a +0.92% move from the previous day.

Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.

Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

Cigna stock gets a Buy rating today. Strengths: dividends, valuation, revenue growth, net income & EPS, share price vs. moving average, capital & liquidity. Offsetting factors:  price performance vs

Health insurer Cigna Group says it has reached a settlement with the United States over claims it overcharged the government's Medicare Advantage program by making it appear patients were more ill tha

In a dramatic return to the financial spotlight, legendary investor Michael Burry, famed for his eerily accurate prediction of the 2008 market crash, seized headlines once more in August.

GARP, or “Growth at a Reasonable Price,” is an investing strategy popularized by Wall Street legend Peter Lynch, who managed the Fidelity Magellan Fund (MUTF: FMAGX ). Peter Lynch's approach garne

Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.

This monthly series of articles focuses on DGI stocks likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualit

Cigna has demonstrated long-term earnings per share growth and has successfully navigated its post-merger phase with Express Scripts. The company's diversification across segments positions it to adap

The new product from Cigna's (CI) Cigna Healthcare unit is likely to face significant demand in the global market.